News from epivax, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 11, 2016, 14:40 ET EpiVax spins out Aceno Biotherapeutics at JP Morgan/Biotech Showcase 2016

 EpiVax, Inc. (EpiVax) today announced the company's participation in a new venture, Aceno Biotherapeutics, a BioSuperior company. Co-founder...


Oct 28, 2015, 17:02 ET Blue Ribbon Biodefense Panel Recommends Vaccines-on-Demand Approach Developed by EpiVax

PROVIDENCE, R.I., Oct. 28, 2015 /PRNewswire/ -- A report released today by former DHS Secretary Tom Ridge, former US Senator Joseph Lieberman and...


Oct 26, 2015, 15:59 ET Ipsen and EpiVax collaborate to produce next generation botulinum toxins

Ipsen (Euronext: IPN; ADR: IPSEY) and the US company EpiVax, Inc. (EpiVax) today announced that they have completed a collaborative project that...


Dec 22, 2014, 10:00 ET EpiVax, Inc. enters license agreement with Novozymes Biopharma to advance pioneering treatment of autoimmune diseases

Novozymes' Veltis® albumin-based half-life extension platform will help move Tregitope treatment for autoimmune diseases closer to clinical...


Oct 30, 2014, 11:17 ET Chugai licenses ISPRI/OptiMatrix platform from EpiVax for de-risking biologics

Chugai Pharmaceutical Co., Ltd. (Chugai), signed an agreement with Rhode Island-based biotechnology company, EpiVax, Inc., to incorporate EpiVax's...


Dec 03, 2013, 06:00 ET Biotest-EpiVax Collaborative Research Targets New, Non-Immunogenic Treatment for Hemophilia A

 Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement....


Apr 24, 2013, 09:00 ET BioAtla Combines EpiVax's Immunogenicity Screening Into Their Express Humanization™ Platform

 Full article – http://bit.ly/EpiAtla13 EpiVax Inc., an unique immunology company with a strong focus on immunogenicity mitigation and...


Apr 13, 2013, 09:00 ET Why H7N9 (Shanghai 2013) is the new stealth virus and what we can do about it.

 Full Story – http://bit.ly/H7N9EpiVax The H7N9 emerging from China is a stealth virus. State of the art bioinforamatics tools...


Feb 12, 2013, 09:00 ET EpiVax-Novozymes Tregitope-Albumin Fusion Moves 'Paradigm-Shifting' Treatment for Diabetes Closer to Clinical Trials

 EpiVax, Inc. is pleased to announce a new Collaborative Research Agreement with Novozymes Biopharma. The collaboration will enable EpiVax to...


Nov 16, 2012, 14:30 ET Funding for Orphan Disease Indication Will Compare EpiVax's Tregitope with IVIG

Full Article Here Providence-based biotech company EpiVax, Inc. was awarded a new $55,000 grant from the GBS-CIDP Foundation International, to...


Nov 26, 2008, 12:00 ET EpiVax Receives NIH Grant for $390,000 to Optimize HIV Vaccine Delivery

EpiVax, Inc., a leader in the field of computational immunology, announced today that it has received a grant from the National Institute of...